Lars Harbaum Selected Research

Rare Diseases (Rare Disease)

1/2021

The application of 'omics' to pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Harbaum Research Topics

Disease

14	Pulmonary Arterial Hypertension 11/2023 - 04/2014
7	Pulmonary Hypertension 01/2022 - 01/2014
5	Colorectal Neoplasms (Colorectal Cancer) 02/2016 - 07/2010
3	Familial Primary Pulmonary Hypertension 03/2023 - 05/2014
3	Emphysema 01/2018 - 12/2016
3	Neoplasms (Cancer) 09/2016 - 07/2010
2	Inflammation (Inflammations) 12/2018 - 04/2014
2	Respiratory Insufficiency (Respiratory Failure) 01/2018 - 01/2017
1	Cough 09/2022
1	Post-Acute COVID-19 Syndrome 04/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pericardial Effusion 10/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Diabetes Mellitus 12/2020
1	Hypertension (High Blood Pressure) 12/2020
1	Coronary Disease (Coronary Heart Disease) 12/2020
1	Obesity 12/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Hypertrophy 01/2020
1	Right Ventricular Hypertrophy 01/2020
1	Hemoptysis 12/2016
1	Hemorrhage 12/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014
1	Renal Insufficiency (Renal Failure) 01/2014
1	Adenocarcinoma 06/2012
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2012
1	Turcot syndrome 06/2012
1	Carcinoma (Carcinomatosis) 01/2012
1	Necrosis 12/2010
1	Disease Progression 07/2010
1	Neoplasm Metastasis (Metastasis) 07/2010

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2014
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2010
2	ProteomeIBA 01/2022 - 01/2022
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2018
2	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 01/2014
2	MucinsIBA 09/2016 - 06/2012
2	Indicators and Reagents (Reagents)IBA 02/2016 - 06/2012
2	Keratin-7 (Cytokeratin 7)IBA 01/2012 - 08/2011
1	apixabanIBA 09/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	TransferasesIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Carbon MonoxideIBA 12/2020
1	Carbon DioxideIBA 11/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2020
1	dimethylarginineIBA 01/2020
1	EnzymesIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	DystrophinIBA 01/2020
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	Ion Channels (Ion Channel)IBA 12/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2016
1	Calcibiotic Root Canal SealerIBA 09/2016
1	Interleukin-17 (Interleukin 17)IBA 10/2015
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 08/2015
1	Fibrinogen (Factor I)FDA Link 04/2014
1	Dasatinib (BMS 354825)FDA Link 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Keratin-20 (Cytokeratin 20)IBA 01/2012
1	Keratins (Keratin)IBA 01/2012
1	ProlactinIBA 07/2010
1	Prolactin Receptors (Prolactin Receptor)IBA 07/2010

Therapy/Procedure

5	Therapeutics 11/2023 - 07/2010
3	Pneumonectomy (Lung Volume Reduction) 01/2018 - 12/2016
1	Precision Medicine 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2018
1	Length of Stay 12/2016
1	Drug Therapy (Chemotherapy) 05/2014